Re: Re: Professional Association Warns Swine flu vaccine unsuitable for patients suffering from environmental diseases and other chronic multi-system illnesses

[Guest guest]

Here's the complete article and the link.

German Medical Association warns:

" Swine flu vaccine " unsuitable for patients suffering from

environmental diseases and other chronic multi-system illnesses

Press release of the German Professional Association of Environmental

Medicine (Deutscher Berufsverband der Umweltmediziner – DBU)

from 26. October 2009

Swine flu vaccine is unsuitable for patients with environmental diseases

and other chronic multi-system illnesses. Pandemrix® poses substantial

health risk with respect to mass immunization programs due to the lack of proof

of safety. Because of the producer’s release from liability by the German

Federal Government (BRD), the risk of adverse reactions and/or permanent damage

due to the vaccine rests with the patient.

The German Professional Association of Environmental Medicine (DBU) has, in

spite of press releases from the BRD, the -Ehrlich-Institute, as well as

the vaccine producer’s assurances of safety, serious concerns relating to

Pandemrix® (GlaxoKline), the only vaccine which has been approved for mass

vaccination by the BRD.

The DBU discusses at this point neither the medical use of immunization in

general nor the necessity of such measures in the, up until now, mild course of

the swine flu pandemic.

Our criticism is directed only against the pandemic vaccine

Pandemrix®.

* There exists considerable doubt as to the effectiveness of the vaccine:

during the licensing phase, the vaccine tested had a 40% higher portion of virus

antigen (5. 25µg) than the vaccine (3.75µg) now being delivered. An

unequivocal consensus has not been reached as to whether the vaccination should

be given once or twice a season !!!

* There exists considerable doubt concerning the safety of the adjuvanted

active amplifier since it is being used for the first time. The vaccine contains

27.4mg AS03, an emulsion of polysorbate, squalene and tocopherol. Sufficient

studies are lacking, because in the test phase, only the development of antibody

titers was determined as a surrogate criterion, and not any potential adverse

reactions.

* The producer as well as government agencies have concealed the fact that

squalene, if used subcutaneously or intramuscularly is an inflammatory immune

activation immunogen, unlike when ingested. (Squalene is, among other things,

for example, naturally contained in olive oil.)

* Autoimmune diseases can be provoked by squalene; already existing ones can be

activated. Squalene has been connected with the emergence of Guillan-Barré

Syndrome (GBS) and is now considered a trigger for Gulf War Syndrome (GWS). In

animal studies squalene brought on rheumatoid arthritis.

* Squalene from food sources is mainly incorporated into membranes in the body.

The production of squaline antibodies resulting from an immunization sets off

chronic inflammation of the membranes, which explains diseases such as Gulf War

Syndrome and also degenerative neurological diseases such as Multiple Sclerosis,

Amyotrophic Lateral Sclerosis, Chronic Inflammatory Demyelinating Polyneuropathy

and Guillan-Barré Syndrome.

* The delivery of vaccine in multiple dose ampules is obsolete. In single dose

ampules the mercury used for preservation, as in thimerosal – which is

included in Pandemrix – would be unnecessary. Also, mercury has been proven

to set off autoimmune diseases.

* Since the vaccine has not been tested on either young children or pregnant

women (Ethics Commission objection), the call to give preference in the first

phase of vaccination to precisely this particularly endangered segment of the

population represents an improper and totally unjustifiable field test.

* The vaccine poses a higher risk than the swine flu itself for patients with

environmental illness and for patients with compromised immune systems (e.g.

AIDS).

* The vaccine producer GlaxoKline (GSK), according to the contract with

the BRD, is largely exempt from liability. In case of damage from the

vaccination, the affected vaccinee would have to sue the government and

therefore the country of Germany, usually a futile exercise.

* To avoid the trap of liability, the doctor giving the vaccination must

meticulously inform the patient of all risks concerning the vaccination and the

vaccine. It is recommended to give this information in the presence of an

assistant and to have it be confirmed by the patient’s signature. The

explanation should also include the liability features. Also the indication that

other, lower risk vaccines are available in Europe and that due to a faulty

decision by the German government, they are currently not available to the

German population. This information should definitely be included in the

explanation.

For general and environmental health considerations the DBU urgently advises

against carrying out a vaccination with Pandemrix.

http://www.csn-deutschland.de/blog/en/german-medical-association-warns-%E2%80%9C\

swine-flu-vaccine%E2%80%9D-unsuitable-for-patients-suffering-from-environmental-\

diseases-and-other-chronic-multi-system-illnesses/